ArticleOncology letters2017

Gene signatures associated with drug resistance to irinotecan and oxaliplatin predict a poor prognosis in patients with colorectal cancer.

Xinrong Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.